Author name: DrugPatentWatch

“Measuring Patent Value Indicators with Patent Renewal Information” aims to address the research gap by constructing a dynamic model that […]

The article “Maximizing the Value of Drug Patents Before Losing Exclusivity” discusses strategies for biomedical companies to maximize the value

In a recent STAT article Sanofi CEO Paul Hudson discusses the potential of artificial intelligence (AI) in the pharmaceutical industry.

In the world of patents, the right to exclude others from using or selling an invention is granted only during

Pharmacists play a crucial role in drug repurposing due to the vast amount of opportunities that exist in this innovative

In a guest column Kevin Wall, principal consultant and owner of Cincero Consulting, emphasizes the critical importance of selecting the

Loss of exclusivity (LOE) doesn’t have to spell doom for branded drug revenue streams. In the face of impending patent

A recent paper in Expert Opinion on Biological Therapy studies failed fillings for biosimilar drugs. Over the past three decades, biotherapeutics

DrugPatentWatch now offers single drug reports for purchase on Amazon. These reports provide valuable insights and information about specific drugs.